Watson Sees 2011 EPS of $3.85 to $4.15

During an investor meeting held today in New York, NY, Watson Pharmaceuticals, Inc. WPI provided an update on its Global businesses, including a detailed overview of its commercial operations and pipeline developments within its Global Generics and Global Brands businesses, and an update of achievements within its Global Operations. In conjunction with the meeting, the Company provided its preliminary 2011 financial and long term growth forecasts. Watson management predicted continued growth in its Global Generics and Global Brand businesses, with 2011 revenues expected to reach approximately $4.2 billion, and adjusted cash earnings per share of between $3.85 and $4.15 for 2011. Watson estimates 2012 adjusted cash earnings per share to increase 20 to 25 percent year-over-year, and in 2013, the Company estimates adjusted cash earnings per share to increase 15 to 20 percent year-over-year.